Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
2 Years PSA Recurrence Rate
Trial Locations (10)

Unknown

Research Site, Beijing

Research Site, Guangzhou

Research Site, Wuhan

Research Site, Nanjing

Research Site, Shenyang

Research Site, Xi’an

Research Site, Chengdu

Research Site, Hangzhou

Research Site, Shanghai

Research Site, Tianjin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY